SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials -- Ignore unavailable to you. Want to Upgrade?


To: EmuGreg who wrote (56)7/3/1999 10:38:00 AM
From: Dave Budde  Read Replies (2) | Respond to of 250
 
EmuGreg, re: "Also, does anyone have any insight as to why the original company (Genetech?) gave the technology away?"

Genentech hardly gave away the technology. They still own 14% of VAXGEN after the IPO and have exclusive manufacturing rights of the vaccine.

I'm guessing they spun this out to get the losses off their current operating results and also to better motivate the developers. Or maybe the developers made this decision for them.